Chemical activators of SLC16A5 can engage with the protein through diverse mechanisms, affecting its transport activity. Iodoacetic acid's inhibition of glycolytic enzymes can lead to increased intracellular pH levels. This environment can activate SLC16A5, which responds to pH changes to transport its substrates across the membrane. Similarly, N-Ethylmaleimide acts by modifying cysteine residues, which can result in conformational alterations of the protein, potentially revealing or modifying the substrate binding site of SLC16A5 or its transport mechanism. Another chemical, DIDS, targets anion exchangers, and its inhibitory action can cause cells to activate SLC16A5 as a compensatory response to maintain ionic homeostasis. Phloretin, which inhibits various glucose transporters, may also lead to the activation of SLC16A5 as the cell seeks to compensate for the disrupted glucose transport.
Additionally, FCCP, acting as a protonophore, disrupts the proton gradient across mitochondrial membranes, which can result in the activation of SLC16A5 as cells attempt to reestablish proton equilibrium. Valinomycin and monensin, as ionophores for potassium and sodium respectively, disrupt intracellular ionic concentrations, which can indirectly lead to the activation of SLC16A5. The protein may become more active as part of the cellular response to reestablish ionic balance and pH levels. Nigericin, which exchanges potassium for hydrogen ions, can alter intracellular pH and thereby activate SLC16A5 as the cell works to rebalance proton levels. Gramicidin increases the membrane permeability for monovalent cations, which can change the electrochemical gradient that SLC16A5 relies on, leading to its activation. Tributyltin chloride and calcimycin, which affect calcium signaling and increase intracellular calcium levels respectively, can also activate SLC16A5 as the cell responds to changes in the calcium environment. Lastly, ouabain inhibits Na+/K+ ATPase, resulting in elevated intracellular sodium levels, which can trigger the activation of SLC16A5 as the cell adjusts to the altered sodium and potassium gradients.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Iodoacetic acid | 64-69-7 | sc-215183 sc-215183A | 10 g 25 g | $57.00 $99.00 | ||
Iodoacetic acid can irreversibly inhibit glycolytic enzymes which may lead to an increase in intracellular pH. Slc16a5, as a proton-linked monocarboxylate transporter, can be activated by changes in pH to transport its substrates across the membrane. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
N-Ethylmaleimide is known to modify cysteine residues on proteins. This chemical modification can result in conformational changes that activate Slc16a5 by exposing or altering its substrate binding site or transport mechanism. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin can inhibit various glucose transporters, potentially causing a compensatory increase in the activity of other transporters like Slc16a5 to maintain metabolic equilibrium. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) acts as a protonophore, uncoupling oxidative phosphorylation by transporting protons across the mitochondrial membrane. This can lead to an activation of Slc16a5 as the cell attempts to maintain proton gradients. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
Valinomycin is a potassium ionophore that disrupts intracellular potassium levels, which can indirectly activate Slc16a5 as the cell works to re-establish ionic balance, potentially through enhanced monocarboxylate transport. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore, and by altering intracellular sodium concentrations, it can indirectly activate Slc16a5 as part of cellular attempts to regulate ionic strength and pH. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
Nigericin acts as a potassium/hydrogen antiporter and can alter intracellular pH. This alteration may lead to the activation of Slc16a5 to re-balance proton levels across the cell membrane. | ||||||
TBTC | 1461-22-9 | sc-251105 | 5 g | $48.00 | ||
Tributyltin chloride affects calcium signaling and may cause an increase in intracellular calcium, which can activate Slc16a5 to adjust to alterations in the cellular environment. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin (A23187) is a calcium ionophore that increases intracellular calcium levels. As cellular mechanisms attempt to restore calcium homeostasis, Slc16a5 activity may be increased as part of the response. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+ ATPase, leading to increased intracellular sodium levels. This ionic imbalance can activate Slc16a5 as the cell compensates for disrupted sodium and potassium gradients. | ||||||